We are live on
!
Find out more
CIC
Cornercap Investment Counsel Portfolio holdings
AUM
$203M
1-Year Est. Return
17.67%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+17.67%
3 Year Est. Return
+55.44%
5 Year Est. Return
+79.88%
10 Year Est. Return
+193.02%
AUM
$338M
AUM Growth
-$276M
(-45%)
Cap. Flow
-$312M
Cap. Flow
% of AUM
-92.38%
Top 10 Holdings %
Top 10 Hldgs %
8.28%
Holding
665
New
63
Increased
10
Reduced
440
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T. Rowe Price
TROW
|
+$1.6M |
| 2 |
Avery Dennison
AVY
|
+$1.51M |
| 3 |
Northern Trust
NTRS
|
+$1.51M |
| 4 |
Biogen
BIIB
|
+$1.48M |
| 5 |
United Parcel Service
UPS
|
+$1.45M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.9M |
| 2 |
Apple
AAPL
|
+$4.69M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$4.44M |
| 4 |
Microsoft
MSFT
|
+$3.55M |
| 5 |
JPMorgan Chase
JPM
|
+$3.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.18% |
| 2 | Technology | 15.49% |
| 3 | Healthcare | 12.24% |
| 4 | Industrials | 11.42% |
| 5 | Consumer Discretionary | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Sutro Biopharma
STRO
$423M
| $64.2K | 0.02% |
1,856
-1,680
| -48% | -$65.9K |
|
502
Voyager Therapeutics
VYGR
$195M
| $64K | 0.02% |
10,937
-12,039
| -52% | -$87.5K |
|
503
Nuvation Bio
NUVB
$2.32B
| $59.1K | 0.02% |
25,811
-29,698
| -54% | -$90.6K |
|
504
Tenaya Therapeutics
TNYA
$165M
| $58.3K | 0.02% |
30,222
-33,616
| -53% | -$94.9K |
|
505
MeiraGTx Holdings
MGTX
$1.21B
| $55.4K | 0.02% |
13,290
-18,426
| -58% | -$79.7K |
|
506
Alector
ALEC
$189M
| $54.8K | 0.02% |
11,767
-12,552
| -52% | -$67.3K |
|
507
TScan Therapeutics
TCRX
$50.1M
| $53.7K | 0.02% |
10,788
-12,152
| -53% | -$73.3K |
|
508
BioAtla
BCAB
$5.76M
| $52.5K | 0.02% |
596
-616
| -51% | -$51.7K |
|
509
CytomX Therapeutics
CTMX
$750M
| $48.9K | 0.01% |
41,458
-39,133
| -49% | -$49.7K |
|
510
Century Therapeutics
IPSC
$357M
| $44.4K | 0.01% |
25,978
-25,037
| -49% | -$49K |
|
511
Verastem
VSTM
$615M
| $35.3K | 0.01% |
11,810
-13,254
| -53% | -$36K |
|
512
Caribou Biosciences
CRBU
$165M
| $32.4K | 0.01% |
16,522
-18,783
| -53% | -$38.5K |
|
513
Adicet Bio
ACET
$75.9M
| $26K | 0.01% |
1,130
-1,287
| -53% | -$28.8K |
|
|
514
Apple
AAPL
$4.5T
| – | – |
-22,286
| Closed | -$4.69M |
|
515
Accenture
ACN
$109B
| – | – |
-6,626
| Closed | -$2.01M |
|
516
Automatic Data Processing
ADP
$109B
| – | – |
-1,023
| Closed | -$244K |
|
517
Autodesk
ADSK
$54.1B
| – | – |
-9,234
| Closed | -$2.28M |
|
518
Aflac
AFL
$61.2B
| – | – |
-7,921
| Closed | -$707K |
|
519
Assurant
AIZ
$14.2B
| – | – |
-7,873
| Closed | -$1.31M |
|
520
Alight
ALIT
$394M
| – | – |
-3,011
| Closed | -$444K |
|
521
Alkermes
ALKS
$8.29B
| – | – |
-39,424
| Closed | -$950K |
|
522
Allstate
ALL
$68.2B
| – | – |
-2,313
| Closed | -$369K |
|
523
ALX Oncology
ALXO
$285M
| – | – |
-10,292
| Closed | -$62.1K |
|
524
Amkor Technology
AMKR
$13.1B
| – | – |
-7,650
| Closed | -$306K |
|
525
Alpha Metallurgical Resources
AMR
$1.95B
| – | – |
-1,747
| Closed | -$490K |
|
Similar funds
NWM
EECFX
PSB
HIA
NMG
EECFX
BC
EFA
Cornercap Investment Counsel's Q3 2024 Portfolio in Review
As of Q3 2024, Cornercap Investment Counsel held 665 positions worth $338M, down 45% from $614M the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
Cornercap Investment Counsel withdrew a net $312M in Q3 2024, closing 152 positions and reducing 440 holdings. Its most notable exit was NVIDIA, an estimated $4.9M position sold in full.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Cornercap Investment Counsel opened a new position in T. Rowe Price worth $1.58M.
- Cornercap Investment Counsel's largest Q3 2024 buy was T. Rowe Price: 14,537 shares worth $1.58M.
- Cornercap Investment Counsel added most to Wells Fargo in Q3 2024, an estimated $1.05M increase.
- Cornercap Investment Counsel's biggest Q3 2024 reduction was Alphabet (Google) Class A, cutting an estimated $4.44M.
- Cornercap Investment Counsel fully exited NVIDIA in Q3 2024, selling an estimated $4.9M.
- Cornercap Investment Counsel's ten largest holdings make up 8.3% of its $338M portfolio in Q3 2024.
- Cornercap Investment Counsel opened 63 new positions and closed 152 in Q3 2024.
- Cornercap Investment Counsel's portfolio value fell 45% quarter-over-quarter to $338M.
Based on Cornercap Investment Counsel's 13F filing for Q3 2024, filed 6 Nov 2024.